Perspective: The Insulin Signaling System--A Common Link in the Pathogenesis of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The maintenance of normal carbohydrate metabolism requires an intricate interplay between insulin action and insulin secretion. Type 2 diabetes usually results from a combination of peripheral insulin resistance and defects in β-cell function. Analysis in humans has identified specific genetic defects associated with early-onset forms of diabetes, but a common molecular mechanism for the majority of cases of type 2 diabetes has yet to be identified. Recent results from a number of murine knockout and transgenic models suggest that disruption of insulin/insulin-like growth factor (IGF)-1 signaling mechanisms, and in particular, alteration in the function of insulin-receptor substrate (IRS) proteins, might contribute to defects in both peripheral insulin action and β-cell function. These studies identify a potential common final pathway to explain the cellular and physiological defects observed in type 2 diabetes. While the exact molecular nature of such defects in humans has yet to be identified, components of the insulin/IGF signaling network and its downstream effector molecules are attractive therapeutic targets for the rationale treatment of this disease. Genetic and physiological studies in diverse organisms from humans to C. elegans provide strong evidence that the insulin/IGF-signaling system is an evolutionarily conserved mechanism integrating fuel metabolism with growth, development, reproduction, and longevity (1). At a cellular level, insulin/IGF-signaling regulates multiple processes, including carbohydrate and lipid metabolism, gene transcription, DNA synthesis, anti-apoptosis, and cell proliferation. Insulin and insulin-like growth factors (IGF-1 and IGF-2) bind to members of the insulin receptor tyrosine kinase family, including the type a and b insulin receptors (IRa and IRb) and the IGF-1 receptor (IGF1r). Insulin and IGF-1 are relatively specific agonists for the insulin and IGF-1 receptors, respectively; however, IGF-2 provides cross-talk between these receptors as it binds with high affinity to the IGF1r, and to IRa that predominates during fetal development (Fig. 1). In postnatal life, insulin is an essential metabolic signal, whereas IGF-1 and IGF-2 promote cell proliferation, differentiation and survival; however, as IGF-1 receptor signals promote pancreatic β-cell survival and expansion, the IGF1/2 might play important roles in the pathogenesis of type 2 diabetes. Whereas the conventional view asserts that diabetic complications arise from the deleterious effects of chronic hyperglycemia, type 2 diabetes might be best understood as a global disorder of insulin/IGF1 signal transduction that ultimately dysregulates gene expression and cell function in a wide range of tissues. The use of transgenic mice provides surprising new insights into the pivotal role of insulin/IGF signal transduction mechanisms in the pathogenesis of type 2 diabetes. Understanding the molecular basis of insulin/IGF signaling might provide a common molecular platform to rectify abnormal insulin action and insulin secretion. The IRS-protein-dependent insulin/IGF-1 signaling cascade. The insulin/IGF family consists of three hormones: insulin, IGF-1, and IGF-2. These hormones bind three receptors: insulin receptor, IGF-1 receptor, and mannose-6-phosphate receptor (M6Pr). The insulin receptor is the primary target for insulin during development and adult life. The IGF-1 receptor is the primary target for IGF-1. IGF-2 binds to the type A insulin receptor during embryonic development and binds the IGF-1 receptor in adults. IGF-2 also binds to the mannose-6-phosphate receptor, which targets the IGF-2 for degradation instead of signaling. Activation of the insulin receptor or the IGF-1 receptor mediates signals primarily via the cytoplasmic proteins IRS-1 and IRS-2, which mediate somatic cell growth and metabolism. Activation of the receptors for insulin and IGF-1 stimulate tyrosine phosphorylation of the IRS-proteins, which bind PI 3-kinase, Grb2/SOS and SHP-2, and other SH2-proteins. The Grb2/SOS complex binds p21ras to activate the MAPK cascade (Erk1/Erk2), which phosphorylates and activates transcription factors like elk1 and c-fos. The activation of PI 3-kinase by IRS-protein produces phospholipids (PI 3,4P2 and PI 3,4,5P3) which activates a variety of downstream kinase cascades, including mTOR → PHAS/p70s6k/eIF4→protein synthesis; PKCs/PKB→GSK3, which might promote glucose uptake and glycogen synthesis; PKB→BAD/FKHRL1, which might promote cell survival. PI 3,4,5P3 is dephosphorylated by the action of PTEN, and SHIP2 converts PI 3,4,5P3 to PI 3,4P2. Insulin resistance is a common element in type 2 diabetes, which is thought to have its greatest impact in certain insulin“ target tissues,” including muscle, adipocytes, and liver; insulin resistance in muscle is frequently cited as the culprit in type 2 diabetes (2, 3). As expected, disruption of the insulin receptor in humans and mice is lethal shortly after birth, owi
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 2×
“cited as the culprit in type 2 diabetes (2, 3).”
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252 · cited 1×
“The complete disruption of the irs-1 gene in mice causes peripheral insulin resistance with nearly normal glucose homeostasis, owing largely to lifelong compensatory hyperinsulinemia (13, 19, 20).”
Cline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675
Cited by
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
von Hurst, P. R., Stonehouse, W., & Coad, J. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509992017 · Cited by 624
“Murine studies have shown phosphatidylinositol 3-kinase and the insulin receptor substrate proteins to be important coordinators of insulin regulation((47)).”
BackgroundInsulin in the brain: There and back again
Banks, W. A., Owen, J. B., & Erickson, M. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.006 · Cited by 574
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., & Van Obberghen, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204152200 · Cited by 539
Metadata
- Authors
- Withers, D. J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-06-01
- Volume
- 141
- Issue
- 6
- Pages
- 1917-1921
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2015449775
- Cited by
- 138
- References
- 3
- FWCI
- 15.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perspective: The Insulin Signaling System--A Common Link in the Pathogenesis of Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/en.141.6.1917
- The paper
- Withers, D. J. (2000). Perspective: The Insulin Signaling System--A Common Link in the Pathogenesis of Type 2 Diabetes. Endocrinology. https://doi.org/10.1210/en.141.6.1917
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.